Enterprise Value
225.3M
Cash
207.7M
Avg Qtr Burn
-43.64M
Short % of Float
15.51%
Insider Ownership
1.31%
Institutional Own.
-
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DYNE-251 Details Duchenne muscular dystrophy | Phase 1/2 Data readout | |
DYNE-101 Details Myotonic Dystrophy Type 1 | Phase 1/2 Data readout |